tetrahydropalmatine has been researched along with Liver Cirrhosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Ding, X; Lan, T; Li, S; Wang, L; Xuan, Y; Yang, G | 1 |
| Cheng, P; Guo, C; Wu, J; Yu, Q | 1 |
2 other study(ies) available for tetrahydropalmatine and Liver Cirrhosis
| Article | Year |
|---|---|
Tetrahydropalmatine attenuates liver fibrosis by suppressing endoplasmic reticulum stress in hepatic stellate cells.
Topics: Berberine Alkaloids; Endoplasmic Reticulum Stress; Hepatic Stellate Cells; Humans; Liver Cirrhosis | 2021 |
PPARγ/NF-κB and TGF-β1/Smad pathway are involved in the anti-fibrotic effects of levo-tetrahydropalmatine on liver fibrosis.
Topics: Animals; Berberine Alkaloids; Biomarkers; Carbon Tetrachloride; Disease Models, Animal; Extracellular Matrix Proteins; Hepatic Stellate Cells; Immunohistochemistry; Liver Cirrhosis; Liver Function Tests; Male; Mice; NF-kappa B; PPAR gamma; Signal Transduction; Smad Proteins; Transforming Growth Factor beta1 | 2021 |